Structural Heart

This structural heart channel includes news, videos, podcasts and other content related to diagnosis and treatment of structural heart disease. Topics covered include heart valve repair and replacement, transcatheter aortic valve replacement (TAVR), transcatheter mitral valve replacement (TMVR), transcatheter tricuspid valve replacement (TTVR), left atrial appendage (LAA) occlusion, heart failure interventional device therapies, and closing holes in the heart using, including occlusion of atrial septal defects (ASDs), ventricular septal defects (VSDs) and patent foramen ovales (PFOs).

News | Heart Valve Technology

 


March 25, 2020 — CroiValve announced the successful first human use of its Duo Tricuspid Coaptation Valve ...

Home March 25, 2020
Home
Videos | Structural Heart Occluders

Interview with Carey Kimmelstiel, M.D., FACP, FACC, director, cardiac catheterization laboratory, director ...

Home March 24, 2020
Home
Videos | Structural Heart

Charles D. Resor, M.D., MSc, assistant director, cardiac catheterization lab, Tufts Medical Center and assistant ...

Home February 27, 2020
Home
A 3-D reconstruction of a cardiac CT scan showing an implanted Medtronic CoreValve TAVR device. Imagine courtesy of TeraRecon. #TAVR #TAVI
Feature | Heart Valve Technology | Dave Fornell, Editor

In August 2019, the U.S. Food and Drug Administration (FDA) expanded the indication for the use of transcatheter aortic ...

Home February 24, 2020
Home
Videos | Heart Valve Technology

Andrew Weintraub, M.D., FACC, associate director, of the Interventional Cardiology and Vascular Center, medical director ...

Home February 18, 2020
Home
News | Left Atrial Appendage (LAA) Occluders

February 3, 2020 — The U.S. Food and Drug Administration (FDA) has approved a the CATALYST trial designed to assess ...

Home February 03, 2020
Home
News | Dave Fornell, Editor

February 3, 2020 — Here is the list of the most popular content on the Diagnostic and Interventional Cardiology (DAIC) m ...

Home February 03, 2020
Home
News | Heart Valve Technology

January 31, 2020 — A new study from the Smidt Heart Institute at Cedars-Sinai and other centers nationwide shows that ...

Home January 31, 2020
Home
Abbott Tendyne TMVR, TMVI system received European CE mark clearance in January 2020. The Abbott Tendyne transcatheter mitral valve replacement (TMVR) system uses an anchor attached to the apex of the heart with a whether line attached to the valve. This helps to keep the valve anchored in the mitral annulus and prevent embolization. This anchor system was used because, unlike the aortic valve, the mitral valve has a very thin landing zone to secure the valve. Prevents LVOT obstruction.
Feature | Heart Valve Technology

January 30, 2020 — The Abbott Tendyne Transcatheter Mitral Valve Implantation (TMVI) system received European CE mark ...

Home January 30, 2020
Home
Videos | Heart Valve Technology

Interview with Andrew Weintraub, M.D., FACC, associate director, of the Interventional Cardiology and Vascular Center ...

Home January 28, 2020
Home
Blog

The key question I am always asked at cardiology conferences is what are the trends and interesting new technologies I ...

Home January 24, 2020
Home
News

January 22, 2020 – BioVentrix Inc., developer of the first transcatheter device for left ventricular remodeling after a ...

Home January 22, 2020
Home
News | Robotic Systems

January 20, 2020 — Research has found that repairing the mitral valve earlier, before the mitral valve prolapse ...

Home January 20, 2020
Home
News | Heart Valve Technology

January 13, 2020 — The U.S. Food and Drug Administration (FDA) has approved clinical trial that will compare the ...

Home January 13, 2020
Home
This photo is from a MitraClip procedure during the University of Colorado visit last December.
Feature | Dave Fornell, Editor
Here are the top performing 25 videos posted to the DAIC website in the past year, based on Google Analytics. These the ...
Home December 30, 2019
Home
Subscribe Now